These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1194928)

  • 1. 6,7-Dihydroxytetrahydroisoquinoline: evidence for in vivo inhibition of intraneuronal monoamine oxidase.
    Cohen G; Katz S
    J Neurochem; 1975 Nov; 25(5):719-22. PubMed ID: 1194928
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of 6,7-dihydroxytetrahydroisoquinoline, salsolinol and tetrahydropapaveroline as inhibitors of monoamine oxidase within the adrenergic nerve plexus of the isolated mouse atrium.
    Katz S; Cohen G
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):217-24. PubMed ID: 1257609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo intraneuronal MAO inhibition in rat brain SKF 64139, comparison to other potent PNMT inhibitors.
    Mefford IN; Roth KA; Gilberg M; Barchas JD
    Eur J Pharmacol; 1981 Mar; 70(3):345-53. PubMed ID: 7227455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):519-22. PubMed ID: 6856953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salsolinol on rat brain and liver monoamine oxidase.
    Yamanaka Y
    Jpn J Pharmacol; 1971 Dec; 21(6):833-6. PubMed ID: 5316871
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships.
    Thull U; Kneubühler S; Gaillard P; Carrupt PA; Testa B; Altomare C; Carotti A; Jenner P; McNaught KS
    Biochem Pharmacol; 1995 Sep; 50(6):869-77. PubMed ID: 7575650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the COMT activity by 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1-(3,5-dimethoxy-4-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in vitro.
    Hattori K; Matsuura M; Shimamoto K
    Jpn J Pharmacol; 1969 Jun; 19(2):287-90. PubMed ID: 5308833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase].
    Kuznetsova LP; Sochilina EE; Faddeeva MD; Iagodina OV
    Ukr Biokhim Zh (1999); 2005; 77(2):147-53. PubMed ID: 16335248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New data on monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro.
    Solomon HM; Ashley C; Spirt N; Abrams WB
    Clin Pharmacol Ther; 1969; 10(2):229-38. PubMed ID: 5775990
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase B inhibition and the "cheese effect".
    Youdim MB; Finberg JP
    J Neural Transm Suppl; 1987; 25():27-33. PubMed ID: 3480939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hycanthone and praziquantel on monoamine oxidase and cholinesterases in Schistosoma mansoni.
    Kim RA; Lukacs J; Tanaka RD; MacInnis AJ
    J Parasitol; 1981 Feb; 67(1):20-3. PubMed ID: 7229816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    J Neurochem; 1962; 9():299-306. PubMed ID: 13888045
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine-derived tetrahydroisoquinoline alkaloids--inhibitors of neuroamine metabolism.
    Collins AC; Cashaw JL; Davis VE
    Biochem Pharmacol; 1973 Sep; 22(18):2337-48. PubMed ID: 4733684
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study.
    Mukherjee J; Yang ZY
    Eur J Pharmacol; 1997 Oct; 337(1):111-4. PubMed ID: 9389388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin.
    Medina MA; Giachetti A; Shore PA
    Biochem Pharmacol; 1969 Apr; 18(4):891-901. PubMed ID: 5788526
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, biological investigation and molecular docking study of N-malonyl-1,2-dihydroisoquinoline derivatives as brain specific and shelf-stable MAO inhibitors.
    Abd El-Gaber MK; Hassan HY; Mahfouz NM; Farag HH; Bekhit AA
    Eur J Med Chem; 2015 Mar; 93():481-91. PubMed ID: 25732770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo-inhibition of serotonin synthesis in mouse brain by beta-phenylethylhydrazine, an inhibitor of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    Biochem Pharmacol; 1962 Jan; 11():45-52. PubMed ID: 13888046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.